Press "Enter" to skip to content

Apricus mulls options; to sell U.S. rights to Vitaros

(Reuters) – Apricus Biosciences Inc said on Monday it was considering options for the company and looking to sell the U.S. rights to its erectile dysfunction cream Vitaros, after the Food and Drug Administration asked it to make a new formula for the product.

Source: Health

Be First to Comment

Leave a Reply